Akanda (AKAN) Receivables - Net (2021 - 2025)

Akanda (AKAN) recorded quarterly Receivables - Net of $370537.0 in Q4 2024, up 30.24% quarter-over-quarter from $284513.0 in Q4 2023, and up 30.24% on a YoY basis from $284513.0 in Q1 2024.

Akanda (AKAN) Receivables - Net (2021 - 2025) Analysis & Trends

Akanda's Receivables - Net history runs 4 years deep, the most recent figure standing at $370537.0 for Q4 2024.

  • In Q4 2024, Receivables - Net rose 30.24% year-over-year to $370537.0; the TTM figure through Dec 2024 stood at $370537.0 (up 30.24% YoY), while the FY2024 annual figure was $370537.0, up 30.24% from the prior year.
  • Receivables - Net was $370537.0 for Q4 2024 at Akanda, up from $284513.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $720085.0 in Q4 2022 to a low of $29457.0 in Q4 2021.
  • Historically, Receivables - Net has averaged $351148.0 across 4 years, with a median of $327525.0 in 2023.
  • The sharpest annual moves came in 2022 and 2023: Receivables - Net surged 2344.53% in 2022, then sank 60.49% in 2023.
  • A 4-year view of Receivables - Net shows it stood at $29457.0 in 2021, then soared by 2344.53% to $720085.0 in 2022, then tumbled by 60.49% to $284513.0 in 2023, then soared by 30.24% to $370537.0 in 2024.
  • The last three Receivables - Net figures came in at $370537.0 (Q4 2024), $284513.0 (Q4 2023), and $720085.0 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Akanda 826.99 Mn 824.46 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 97,627.00
Dec 31, 2025 97,627.00
Dec 31, 2024 370,537.00
Dec 31, 2024 370,537.00
Dec 31, 2023 284,513.00
Dec 31, 2023 284,513.00
Dec 31, 2022 720,085.00
Dec 31, 2022 720,085.00
Dec 31, 2021 242,357.00
Dec 31, 2021 242,357.00